EUVIMEDEUVIMED entdecken
Fallbericht

Enzyme replacement therapy in cholesteryl ester storage disease: A case report on lysosomal acid lipase deficiency management

Marisol Ibarra-Ramírez, Leonor Hinojosa-Amaya, Idalia Cura-Esquivel, Ulises Torres-Flores, Laura E Martínez de Villarreal

Journal of Clinical Lipidology · 2025

DOI: 10.1016/j.jacl.2025.08.005 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Lipidology, 2025. Verfasst von Marisol Ibarra-Ramírez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Department, University Hospital, "José Eleuterio González" and Medicine Faculty, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, …. Hauptthemen laut MEDLINE: Wolman Disease, Cholesterol Ester Storage Disease, Enzyme Replacement Therapy, Sterol Esterase. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Autonomous University of Nuevo Leon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lysosomal acid lipase deficiency (LAL-D) is a rare autosomal recessive disorder caused by pathogenic variants in the LIPA gene. The clinical spectrum ranges from early-onset Wolman disease to later presentations in childhood and adulthood, formerly known as cholesteryl ester storage disease (CESD). Impaired lysosomal acid lipase (LAL) activity leads to the accumulation of cholesteryl esters and triglycerides, causing progressive hepatic and metabolic dysfunction. CASE PRESENTATION: We describe a 17-year-old Mexican female diagnosed with CESD at age 13 after evaluation for short stature and severe hypercholesterolemia. Laboratory workup revealed markedly elevated liver enzymes and lipid levels, with severely reduced LAL activity. Molecular testing identified a homozygous LIPA(NM_000235.3):c.894G>A variant. Enzyme replacement therapy (ERT) with sebelipase alfa (1 mg/kg biweekly) was initiated, leading to progressive normalization of lipid and hepatic profiles. Over a 48-month follow-up, the patient exhibited catch-up growth (gain of 17 cm and 21 kg), pubertal development with the onset of menarche at age 16, and achievement of Tanner stage III. CONCLUSION: This case underscores the importance of early recognition of CESD in patients with unexplained dyslipidemia, elevated liver enzymes, and growth delay. Timely initiation of sebelipase alfa resulted in favorable biochemical and clinical outcomes. Comprehensive diagnostic evaluation-including enzymatic and genetic testing-is critical for accurate diagnosis and personalized management of LAL-D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wolman DiseaseCholesterol Ester Storage DiseaseEnzyme Replacement TherapySterol EsteraseHumansFemaleAdolescent

Stichwörter der Autor:innen

Enzyme replacementGrowth delayHypercholesterolemiaLysosomal acid lipaseSebelipase alfa

Substanzen

Sterol EsteraseSebelipase alfaLIPA protein, human

Autor:innen und Institutionen

  • Genetics Department, University Hospital, "José Eleuterio González" and Medicine Faculty, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, Mexico (Drs Ibarra-Ramírez and Martínez de Villarreal). Electronic add…
  • Pediatrics Department, University Hospital, "José Eleuterio González" and Medicine Faculty, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, Mexico (Drs Hinojosa-Amaya and Cura-Esquivel).
  • AstraZeneca, México City, México (Dr Torres-Flores).
  • Genetics Department, University Hospital, "José Eleuterio González" and Medicine Faculty, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, Mexico (Drs Ibarra-Ramírez and Martínez de Villarreal).

Förderung

  • Autonomous University of Nuevo Leon

Zitieren

APA

Ibarra-Ramírez, M., Hinojosa-Amaya, L., Cura-Esquivel, I., Torres-Flores, U., & Martínez de Villarreal, L. E. (2025). Enzyme replacement therapy in cholesteryl ester storage disease: A case report on lysosomal acid lipase deficiency management. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2025.08.005

Vancouver

Ibarra-Ramírez M, Hinojosa-Amaya L, Cura-Esquivel I, Torres-Flores U, Martínez de Villarreal LE. Enzyme replacement therapy in cholesteryl ester storage disease: A case report on lysosomal acid lipase deficiency management. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2025.08.005

BibTeX
@article{IbarraRamrez2025,
  author = {Ibarra-Ramírez, Marisol and Hinojosa-Amaya, Leonor and Cura-Esquivel, Idalia and Torres-Flores, Ulises and Martínez de Villarreal, Laura E},
  title = {Enzyme replacement therapy in cholesteryl ester storage disease: A case report on lysosomal acid lipase deficiency management},
  journal = {Journal of Clinical Lipidology},
  year = {2025},
  doi = {10.1016/j.jacl.2025.08.005}
}
Kostenlos starten →